Srinivasaraghavan Kannan
Agency for Science, Technology and Research(SG)Bioinformatics Institute(SG)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer, Liver physiology and pathology, Histone Deacetylase Inhibitors Research, FOXO transcription factor regulation
Most-Cited Works
- → FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer(2020)131 cited
- → Computer- and structure-based lead design for epigenetic targets(2011)19 cited
- → Disrupting the Dok3–Card9 Interaction with Synthetic Peptides Enhances Antifungal Effector Functions of Human Neutrophils(2023)6 cited
- → Abstract 5239: Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation(2022)2 cited
- → Design-Rules for Stapled Alpha-Helical Peptides with On-Target In Vivo Activity: Application to Mdm2/X dual antagonists(2023)2 cited
- → Molecular modeling and interaction between Arabidopsis sulfite oxidase and the GW motif of Turnip crinkle virus coat protein(2020)2 cited
- → Responsiveness of different MET tumour alterations to type I and type II MET inhibitors(2025)1 cited
- → Abstract 3439: FOXA1 mutations reveal distinct chromatin profiles and influence therapeutic response in breast cancer(2020)1 cited
- → Faculty Opinions recommendation of Inhibiting epidermal growth factor receptor at a distance.(2014)
- → Novel Inhibitors of the Calcium-Activated K+ Channel KCa3.1 to Treat Non-Alcoholic Fatty Liver Disease and Liver Fibrosis(2019)